Protagonist Therapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BLACKROCK FUNDING, INC. /DE | 02/07/2025 | 9.88 M | $381.55 M | -3.32% | 16.00% |
| FARALLON CAPITAL MANAGEMENT LLC | 02/14/2025 | 5.93 M | $228.90 M | 1.18% | 9.60% |
| RTW INVESTMENTS, LP | 02/14/2025 | 5.50 M | $212.24 M | 1.33% | 8.90% |
| VANGUARD GROUP INC | 02/11/2025 | 4.22 M | $162.89 M | 0.09% | 6.83% |
| JOHNSON & JOHNSON | 02/13/2025 | 2.45 M | $94.54 M | 0.00% | 3.97% |
| BVF INC/IL | 02/14/2025 | 1.90 M | $73.34 M | 2.69% | 3.08% |
| PACER ADVISORS, INC. | 01/22/2025 | 1.88 M | $72.43 M | 8.21% | 3.04% |
| JEFFERIES FINANCIAL GROUP INC. | 02/27/2025 | 1.49 M | $57.49 M | -17.92% | 2.41% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 02/14/2025 | 1.39 M | $53.76 M | 6.35% | 2.25% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/12/2025 | 1.38 M | $53.17 M | 0.17% | 2.23% |
| PERCEPTIVE ADVISORS LLC | 02/14/2025 | 1.27 M | $49.09 M | -7.49% | 2.06% |
| ADAR1 CAPITAL MANAGEMENT, LLC | 02/13/2025 | 1.02 M | $39.38 M | 3.98% | 1.65% |
| DEEP TRACK CAPITAL, LP | 02/14/2025 | 1.00 M | $38.60 M | 100.00% | 1.62% |
| WELLINGTON MANAGEMENT GROUP LLP | 02/12/2025 | 940,077 | $36.29 M | 3,025.36% | 1.52% |
| AMERICAN CENTURY COMPANIES INC | 02/11/2025 | 928,286 | $35.83 M | 61.50% | 1.50% |
| GOLDMAN SACHS GROUP INC | 02/11/2025 | 758,690 | $29.29 M | -7.69% | 1.23% |
| INVESCO LTD. | 02/13/2025 | 738,952 | $28.52 M | 13.14% | 1.20% |
| EVERSEPT PARTNERS, LP | 02/14/2025 | 678,787 | $26.20 M | 52.47% | 1.10% |
| WOODLINE PARTNERS LP | 02/14/2025 | 582,327 | $22.48 M | 24.82% | 0.94% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/06/2025 | 578,409 | $22.33 M | 2.28% | 0.94% |
| JPMORGAN CHASE & CO | 02/12/2025 | 576,977 | $22.27 M | 14.71% | 0.93% |
| FMR LLC | 02/13/2025 | 442,516 | $17.08 M | -2.57% | 0.72% |
| COLONY GROUP, LLC | 02/14/2025 | 425,557 | $16.43 M | -0.26% | 0.69% |
| 683 CAPITAL MANAGEMENT, LLC | 02/14/2025 | 410,000 | $15.83 M | -2.38% | 0.66% |
| MANGROVE PARTNERS | 02/14/2025 | 395,383 | $15.26 M | -10.00% | 0.64% |
| KYNAM CAPITAL MANAGEMENT, LP | 02/14/2025 | 390,792 | $15.08 M | -14.37% | 0.63% |
| BANK OF NEW YORK MELLON CORP | 02/04/2025 | 390,788 | $15.08 M | 9.67% | 0.63% |
| POLAR CAPITAL HOLDINGS PLC | 02/14/2025 | 350,000 | $13.51 M | 0.00% | 0.57% |
| TORONTO DOMINION BANK | 02/19/2025 | 340,974 | $13.16 M | 100.00% | 0.55% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 02/14/2025 | 339,698 | $13.11 M | -23.72% | 0.55% |
| PRINCIPAL FINANCIAL GROUP INC | 01/31/2025 | 337,809 | $13.04 M | 5.29% | 0.55% |
| KENNEDY CAPITAL MANAGEMENT LLC | 02/13/2025 | 321,526 | $12.41 M | 20.41% | 0.52% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 02/14/2025 | 312,319 | $12.06 M | -3.30% | 0.51% |
| SKANDINAVISKA ENSKILDA BANKEN AB (PUBL) | 02/10/2025 | 310,650 | $11.96 M | 35.00% | 0.50% |
| RAYMOND JAMES FINANCIAL INC | 02/13/2025 | 303,313 | $11.71 M | 100.00% | 0.49% |
| PICTET ASSET MANAGEMENT HOLDING SA | 02/12/2025 | 296,511 | $11.45 M | 3,962.91% | 0.48% |
| ARTIA GLOBAL PARTNERS LP | 02/14/2025 | 293,851 | $11.34 M | 136.14% | 0.48% |
| UBS ASSET MANAGEMENT AMERICAS INC | 02/14/2025 | 287,911 | $11.11 M | -21.79% | 0.47% |
| SOLEUS CAPITAL MANAGEMENT, L.P. | 02/14/2025 | 275,000 | $10.62 M | 100.00% | 0.45% |
| VICTORY CAPITAL MANAGEMENT INC | 02/06/2025 | 240,817 | $9.30 M | 84.12% | 0.39% |
| DIMENSIONAL FUND ADVISORS LP | 02/13/2025 | 225,600 | $8.71 M | 0.00% | 0.37% |
| RENAISSANCE TECHNOLOGIES LLC | 02/13/2025 | 221,167 | $8.54 M | 53.41% | 0.36% |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 02/12/2025 | 216,069 | $8.34 M | 36.69% | 0.35% |
| TD ASSET MANAGEMENT INC | 02/11/2025 | 173,702 | $6.70 M | 0.87% | 0.28% |
| RHUMBLINE ADVISERS | 01/30/2025 | 161,964 | $6.25 M | -1.35% | 0.26% |
| MAN GROUP PLC | 02/14/2025 | 157,963 | $6.10 M | 182.93% | 0.26% |
| LEGAL & GENERAL GROUP PLC | 02/13/2025 | 152,562 | $5.89 M | -3.08% | 0.25% |
| NUVEEN ASSET MANAGEMENT, LLC | 02/14/2025 | 151,197 | $5.84 M | -34.85% | 0.24% |
| AQR CAPITAL MANAGEMENT LLC | 02/14/2025 | 150,097 | $5.79 M | 9.42% | 0.24% |
| PUBLIC SECTOR PENSION INVESTMENT BOARD | 02/14/2025 | 148,489 | $5.73 M | 18.84% | 0.24% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Protagonist Therapeutics, Inc. institutional Ownership - FAQ's
During the previous two years, 302 institutional investors and hedge funds held shares of Protagonist Therapeutics, Inc.. The most heavily invested institutionals were:
BlackRock Funding, Inc. /DE: 9.88 M
FARALLON CAPITAL MANAGEMENT LLC: 5.93 M
RTW INVESTMENTS, LP: 5.5 M
VANGUARD GROUP INC: 4.22 M
JOHNSON & JOHNSON: 2.45 M
BVF INC/IL: 1.9 M
102.40% of Protagonist Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 70.71 M shares in the last 24 months. This purchase volume represents approximately $2.69 B in transactions.